covaxin: DGCI to review applications for full market approval of Covaxin, Covishield today | India News – Times of India

New Delhi: A subject matter expert committee headed by India’s Drug Controller General (DCGI) will on Friday review applications from India Biotech and SII for full market approval in Covaxin and Covishield.
The move comes after Hyderabad-based India Biotech announced on Thursday that its home-made Covid-19 vaccine Kovacin is now a universal vaccine for adults and children.
In an application sent to the Drug Controller General (DCGI) of India this week, V Krishna Mohan, full-time director of the Hyderabad-based company, submitted complete information on chemistry, production and control, including pre-clinical and clinical data, regular market approvals for Covaxin. Wanting
Earlier, the manufacturer claimed that its covid vaccine could neutralize both the delta and omicron variants of the covacin coronavirus.

The Serum Institute of India has already made a similar application for Covishield and both applications will be reviewed by the Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI).

!function(f,b,e,v,n,t,s) {if(f.fbq)return;n=f.fbq=function(){n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}; if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version=’2.0′; n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0]; s.parentNode.insertBefore(t,s)}(window, document,’script’, ‘’); fbq(‘init’, ‘593671331875494’); fbq(‘track’, ‘PageView’); .

Read More World News

Keep Reading Latest Breaking News

Source link


Leave a Comment